Gram Positive Bacterial Infections Completed Phase 1 Trials for Daptomycin (DB00080)

Also known as: Gram Positive Bacterial Infection / Infections, Gram-Positive Bacterial / Gram-positive Bacterial Infection / Gram-Positive Bacterial Infections / Bacterial infectious disease (disorder) / Bacterial infection / Bacterial Infections / Bacterial infection of unspecified site / Bacterial infection by site (disorder) / Bacterial infectious disorders / Bacterial infection NOS (disorder) / Bacterial infection NOS / Infection bacterial / Bacterial diseases NOS / Bacterial diseases NOS (disorder) / Bacterial diseases (& [excl TB]) / Bacterial infection, unspecified / [X]Bacterial infection, unspecified (disorder)

IndicationStatusPhase
DBCOND0070817 (Gram Positive Bacterial Infections)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01019395Pharmacokinetics (PK) and Safety Evaluation of Daptomycin in Children Ages 3-24 Months With Proven or Suspected Gram-positive Infections or Peri-Operative Subjects Receiving Prophylactic AntibioticsBasic Science
NCT00136292Study of Single Dose Daptomycin in Pediatric Patients With Gram-positive Infection for Which They Are Receiving Standard Antibiotics